Sit Investment Associates Inc. Has $31.82 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Sit Investment Associates Inc. decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 10.7% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 62,896 shares of the healthcare conglomerate’s stock after selling 7,563 shares during the quarter. UnitedHealth Group accounts for approximately 0.7% of Sit Investment Associates Inc.’s holdings, making the stock its 27th biggest holding. Sit Investment Associates Inc.’s holdings in UnitedHealth Group were worth $31,817,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in the business. NewSquare Capital LLC acquired a new stake in UnitedHealth Group during the fourth quarter valued at approximately $25,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at $30,000. Promus Capital LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at $32,000. Pillar Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth about $40,000. Finally, DecisionPoint Financial LLC boosted its position in UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after buying an additional 62 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $524.94 on Friday. The company has a market capitalization of $480.17 billion, a price-to-earnings ratio of 33.87, a P/E/G ratio of 1.37 and a beta of 0.62. The firm’s 50 day simple moving average is $509.24 and its 200 day simple moving average is $542.37. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.83 EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is currently 54.19%.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.33% of the stock is owned by insiders.

Analyst Ratings Changes

Several research analysts have recently commented on the company. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. KeyCorp restated an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Truist Financial decreased their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Twenty investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.